Van der Valk et al evaluated antibiotic therapy for patients with an exacerbation of chronic obstructive pulmonary disease (COPD). They identified a group of patients who do not benefit from antibiotic therapy. The authors are from Medisch Spectrum Twente, regional Laboratory of Public Health, and University medical Centre Nijmegen in The Netherlands.